In this webinar, we will discuss:
Understand the drawbacks of standard immunoassays such as ELISA tests- Understand that affinity-based antibody profiling is key for a comprehensive understanding of the immune response against SARS-CoV-2
- Learn about the ability to assess the immune response of COVID-19 patients directly in minimally diluted serum by use of a novel in-solution immunoassay platform
- Understand how this technology can be leveraged by scientists in the fight against COVID-19
You can find out more and save your spot by registering here
